FDA Approves New Bimatoprost Solution for Glaucoma Treatment

The Food and Drug Administration (FDA) has announced that the new bimatoprost 0.01% ophthalmic solution has received approval for use in treating increased intraocular pressure in open-angle glaucoma and ocular hypertension patients. The medication is produced by Allergan and will be sold under the name Lumigan.Allergan has been marketing a 0.03% formulation of Lumigan for years. The new